Published in AIDS Weekly, August 28th, 2006
Study 1: Nevirapine resistance decreases survival time associated with nevirapine-based antiretroviral therapy.
"Nevirapine (NVP) resistance may decrease the effectiveness of viral suppression with NVP-based antiretroviral therapy (ART) in women infected with human immunodeficiency virus (HIV) with previous exposure to single-dose NVP. However, the alternative lopinavir-ritonavir-based ART regimen is more expensive," researchers in the United States report.
According to C.B. Holmes and colleagues at Massachusetts General Hospital in Boston,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.